JP2002514623A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002514623A5 JP2002514623A5 JP2000548303A JP2000548303A JP2002514623A5 JP 2002514623 A5 JP2002514623 A5 JP 2002514623A5 JP 2000548303 A JP2000548303 A JP 2000548303A JP 2000548303 A JP2000548303 A JP 2000548303A JP 2002514623 A5 JP2002514623 A5 JP 2002514623A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- phenyl
- propylamine
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 3
- -1 benzenesulfonamido Chemical group 0.000 description 3
- YYOHEGJBKTVTLK-UHFFFAOYSA-N 2,4-dichloro-n-[4-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound C1=CC(CCNCCC)=CC=C1NS(=O)(=O)C1=CC=C(Cl)C=C1Cl YYOHEGJBKTVTLK-UHFFFAOYSA-N 0.000 description 1
- DOFFSUIUWSPOJI-UHFFFAOYSA-N 2-chloro-4-fluoro-n-[4-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound C1=CC(CCNCCC)=CC=C1NS(=O)(=O)C1=CC=C(F)C=C1Cl DOFFSUIUWSPOJI-UHFFFAOYSA-N 0.000 description 1
- XUAUSHRTHCVYEJ-UHFFFAOYSA-N 2-fluoro-n-[3-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound CCCNCCC1=CC=CC(NS(=O)(=O)C=2C(=CC=CC=2)F)=C1 XUAUSHRTHCVYEJ-UHFFFAOYSA-N 0.000 description 1
- GYCXCBYOHASGSD-UHFFFAOYSA-N 3-chloro-n-[3-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound CCCNCCC1=CC=CC(NS(=O)(=O)C=2C=C(Cl)C=CC=2)=C1 GYCXCBYOHASGSD-UHFFFAOYSA-N 0.000 description 1
- GLBXYJLKQWSMHH-UHFFFAOYSA-N 4-bromo-n-[4-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound C1=CC(CCNCCC)=CC=C1NS(=O)(=O)C1=CC=C(Br)C=C1 GLBXYJLKQWSMHH-UHFFFAOYSA-N 0.000 description 1
- VCHHCUQGXMWXAM-UHFFFAOYSA-N 4-chloro-n-[4-[2-(propylamino)ethyl]phenyl]benzenesulfonamide Chemical compound C1=CC(CCNCCC)=CC=C1NS(=O)(=O)C1=CC=C(Cl)C=C1 VCHHCUQGXMWXAM-UHFFFAOYSA-N 0.000 description 1
- 102000004073 Dopamine D3 Receptors Human genes 0.000 description 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- JGGQWSXZZQPZTR-UHFFFAOYSA-N n-[4-[2-(propylamino)ethyl]phenyl]-4-(trifluoromethoxy)benzenesulfonamide Chemical compound C1=CC(CCNCCC)=CC=C1NS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1 JGGQWSXZZQPZTR-UHFFFAOYSA-N 0.000 description 1
- XCVNDBIXFPGMIW-UHFFFAOYSA-N n-ethylpropan-1-amine Chemical compound CCCNCC XCVNDBIXFPGMIW-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- GCWGADZVRFZLBG-UHFFFAOYSA-N tert-butyl 2-[2-(4-aminophenyl)ethylamino]butanoate Chemical compound CC(C)(C)OC(=O)C(CC)NCCC1=CC=C(N)C=C1 GCWGADZVRFZLBG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8549398P | 1998-05-14 | 1998-05-14 | |
| US60/085,493 | 1998-05-14 | ||
| PCT/US1999/007023 WO1999058499A1 (en) | 1998-05-14 | 1999-05-07 | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002514623A JP2002514623A (ja) | 2002-05-21 |
| JP2002514623A5 true JP2002514623A5 (https=) | 2006-08-10 |
Family
ID=22191975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000548303A Withdrawn JP2002514623A (ja) | 1998-05-14 | 1999-05-07 | ドーパミン受容体として有用なフェニルスルホンアミド−フェニルエチルアミン |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6103766A (https=) |
| EP (1) | EP1077935B1 (https=) |
| JP (1) | JP2002514623A (https=) |
| KR (1) | KR20010043546A (https=) |
| CN (1) | CN1152857C (https=) |
| AT (1) | ATE253045T1 (https=) |
| AU (1) | AU752543B2 (https=) |
| BR (1) | BR9910405A (https=) |
| CA (1) | CA2327345A1 (https=) |
| DE (1) | DE69912419T2 (https=) |
| DK (1) | DK1077935T3 (https=) |
| EA (1) | EA002918B1 (https=) |
| ES (1) | ES2211078T3 (https=) |
| HU (1) | HUP0101746A3 (https=) |
| IL (1) | IL139263A0 (https=) |
| NO (1) | NO20005732L (https=) |
| NZ (1) | NZ508152A (https=) |
| PL (1) | PL343891A1 (https=) |
| PT (1) | PT1077935E (https=) |
| SK (1) | SK16242000A3 (https=) |
| TR (1) | TR200003325T2 (https=) |
| TW (1) | TW450954B (https=) |
| WO (1) | WO1999058499A1 (https=) |
| ZA (1) | ZA200005921B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2300119T3 (es) * | 1997-02-27 | 2008-06-01 | Takeda Pharmaceutical Company Limited | Compuestos de amina, su produccion y su uso como inhibidores de la produccion de beta-amiloide. |
| WO2002089785A1 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| WO2002089740A2 (en) * | 2001-05-07 | 2002-11-14 | Smithkline Beecham Corporation | Sulfonamides |
| EP1812389B1 (en) | 2004-10-14 | 2011-08-17 | Abbott GmbH & Co. KG | Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| CA2583983C (en) | 2004-10-14 | 2013-07-16 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| ATE540922T1 (de) | 2004-10-14 | 2012-01-15 | Abbott Gmbh & Co Kg | Zur behandlung von erkrankungen, die auf eine modulation des dopamin-d3-rezeptors ansprechen, geeignete aminoethylaromatische verbindungen |
| ATE496031T1 (de) * | 2006-04-14 | 2011-02-15 | Abbott Gmbh & Co Kg | Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen |
| AR060462A1 (es) | 2006-04-14 | 2008-06-18 | Abbott Gmbh & Co Kg | Compuestos de ariloxietilamina apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3 |
| BRPI0710177A2 (pt) | 2006-04-19 | 2012-05-29 | Abbott Gmbh & Co Kg | arilsulfonas heterocìclicas adequadas para tratar distúrbios que respondem à modulação do receptor 5ht6 de serotonina |
| WO2007118900A1 (en) | 2006-04-19 | 2007-10-25 | Abbott Gmbh & Co. Kg | Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
| WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574741A (en) * | 1969-04-14 | 1971-04-13 | Mead Johnson & Co | Sulfonamidophenalkylamines |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| GB9402197D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Compounds |
| EP0793653A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| WO1997043262A1 (en) * | 1996-05-11 | 1997-11-20 | Smithkline Beecham P.L.C. | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| US5922770A (en) * | 1996-07-22 | 1999-07-13 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| JPH1180156A (ja) * | 1997-09-04 | 1999-03-26 | Hokuriku Seiyaku Co Ltd | １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体 |
-
1999
- 1999-04-26 TW TW088106644A patent/TW450954B/zh not_active IP Right Cessation
- 1999-05-07 KR KR1020007012661A patent/KR20010043546A/ko not_active Abandoned
- 1999-05-07 CA CA002327345A patent/CA2327345A1/en not_active Abandoned
- 1999-05-07 WO PCT/US1999/007023 patent/WO1999058499A1/en not_active Ceased
- 1999-05-07 BR BR9910405-9A patent/BR9910405A/pt not_active Application Discontinuation
- 1999-05-07 HU HU0101746A patent/HUP0101746A3/hu unknown
- 1999-05-07 DE DE69912419T patent/DE69912419T2/de not_active Expired - Fee Related
- 1999-05-07 PL PL99343891A patent/PL343891A1/xx unknown
- 1999-05-07 JP JP2000548303A patent/JP2002514623A/ja not_active Withdrawn
- 1999-05-07 ES ES99919771T patent/ES2211078T3/es not_active Expired - Lifetime
- 1999-05-07 SK SK1624-2000A patent/SK16242000A3/sk unknown
- 1999-05-07 TR TR2000/03325T patent/TR200003325T2/xx unknown
- 1999-05-07 AT AT99919771T patent/ATE253045T1/de not_active IP Right Cessation
- 1999-05-07 NZ NZ508152A patent/NZ508152A/xx unknown
- 1999-05-07 PT PT99919771T patent/PT1077935E/pt unknown
- 1999-05-07 EA EA200001184A patent/EA002918B1/ru not_active IP Right Cessation
- 1999-05-07 AU AU37418/99A patent/AU752543B2/en not_active Ceased
- 1999-05-07 DK DK99919771T patent/DK1077935T3/da active
- 1999-05-07 IL IL13926399A patent/IL139263A0/xx not_active IP Right Cessation
- 1999-05-07 US US09/306,748 patent/US6103766A/en not_active Expired - Fee Related
- 1999-05-07 EP EP99919771A patent/EP1077935B1/en not_active Expired - Lifetime
- 1999-05-07 CN CNB998052175A patent/CN1152857C/zh not_active Expired - Fee Related
-
2000
- 2000-10-23 ZA ZA200005921A patent/ZA200005921B/en unknown
- 2000-11-13 NO NO20005732A patent/NO20005732L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2361860C2 (ru) | Новые замещенные 3-сера-индолы | |
| JP2002543183A5 (https=) | ||
| JP2004532209A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| JP2008523126A5 (https=) | ||
| JP2004517087A5 (https=) | ||
| JP2004517049A5 (https=) | ||
| JP2002516314A5 (https=) | ||
| JP2002514623A5 (https=) | ||
| JP2002534519A5 (https=) | ||
| JP2003531118A5 (https=) | ||
| JP2005507918A5 (https=) | ||
| JP2002030084A5 (https=) | ||
| JPH10279578A5 (https=) | ||
| JP2002518502A5 (https=) | ||
| JP2003503449A5 (https=) | ||
| JP2003502367A5 (https=) | ||
| JP2002510671A5 (https=) | ||
| JP2006516626A5 (https=) | ||
| JP2003522741A5 (https=) | ||
| JP2002522386A5 (https=) | ||
| JP2002526530A5 (https=) | ||
| JPH10130212A5 (https=) | ||
| DK1256581T3 (da) | Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation | |
| JP2001518468A5 (https=) |